Invention Grant
US08536310B2 Antibodies to CLL-1 有权
CLL-1抗体

Antibodies to CLL-1
Abstract:
Anti-CLL-1 antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind CLL-1 and treat diseases, such as hematologic malignancies, which are characterized by expression of CLL-1.
Public/Granted literature
Information query
Patent Agency Ranking
0/0